FI933551A7 - 5-heteroyyli-indolijohdannaisia - Google Patents
5-heteroyyli-indolijohdannaisia Download PDFInfo
- Publication number
- FI933551A7 FI933551A7 FI933551A FI933551A FI933551A7 FI 933551 A7 FI933551 A7 FI 933551A7 FI 933551 A FI933551 A FI 933551A FI 933551 A FI933551 A FI 933551A FI 933551 A7 FI933551 A7 FI 933551A7
- Authority
- FI
- Finland
- Prior art keywords
- heteroyl
- indole derivatives
- indole
- derivatives
- heteroyl indole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65471291A | 1991-02-12 | 1991-02-12 | |
| PCT/US1992/000556 WO1992013856A1 (en) | 1991-02-12 | 1992-02-03 | 5-heteroyl indole derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI933551A7 true FI933551A7 (fi) | 1993-08-11 |
| FI933551L FI933551L (fi) | 1993-08-11 |
| FI933551A0 FI933551A0 (fi) | 1993-08-11 |
Family
ID=24625959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI933551A FI933551A0 (fi) | 1991-02-12 | 1992-02-03 | 5-heteroylindolderivat |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0571471B1 (OSRAM) |
| JP (1) | JPH07121942B2 (OSRAM) |
| KR (1) | KR930703305A (OSRAM) |
| AT (1) | ATE135005T1 (OSRAM) |
| AU (1) | AU655456B2 (OSRAM) |
| CA (1) | CA2101521A1 (OSRAM) |
| CZ (1) | CZ165693A3 (OSRAM) |
| DE (1) | DE69208868T2 (OSRAM) |
| DK (1) | DK0571471T3 (OSRAM) |
| ES (1) | ES2084347T3 (OSRAM) |
| FI (1) | FI933551A0 (OSRAM) |
| GR (1) | GR3019778T3 (OSRAM) |
| HU (1) | HUT65766A (OSRAM) |
| IE (1) | IE920442A1 (OSRAM) |
| IL (1) | IL100888A0 (OSRAM) |
| MX (1) | MX9200569A (OSRAM) |
| MY (1) | MY131298A (OSRAM) |
| NO (1) | NO932859L (OSRAM) |
| NZ (1) | NZ241584A (OSRAM) |
| PT (1) | PT100114A (OSRAM) |
| TW (1) | TW263508B (OSRAM) |
| WO (1) | WO1992013856A1 (OSRAM) |
| YU (1) | YU13792A (OSRAM) |
| ZA (1) | ZA92969B (OSRAM) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW288010B (OSRAM) * | 1992-03-05 | 1996-10-11 | Pfizer | |
| JP2644088B2 (ja) * | 1992-04-07 | 1997-08-25 | フアイザー・インコーポレイテツド | ５−ｈｔ１作動薬としてのインドール誘導体 |
| GB9211277D0 (en) | 1992-05-28 | 1992-07-15 | Glaxo Group Inc | Pharmaceutical compositions |
| GB9226537D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| GB9226532D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| ES2070087B1 (es) * | 1993-08-13 | 1996-02-16 | Pfizer | Derivados de indol |
| US5468768A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antimigraine derivatives of indolylcycloalkanylamines |
| US6423731B2 (en) | 1994-01-06 | 2002-07-23 | Zeneca Limited | Indole derivatives as prodrugs of 5-HT1-like receptor agonists |
| WO1995032196A1 (en) * | 1994-05-19 | 1995-11-30 | Merck Sharp & Dohme Limited | Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
| WO1995032966A1 (en) * | 1994-06-01 | 1995-12-07 | Zeneca Limited | Indole derivatives as prodrugs of 5-ht1-like receptor agonists |
| US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
| US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
| GB9501865D0 (en) * | 1995-01-31 | 1995-03-22 | Merck Sharp & Dohme | Therapeutic agents |
| NZ305166A (en) * | 1995-03-20 | 1998-12-23 | Lilly Co Eli | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments |
| US5942536A (en) * | 1995-10-10 | 1999-08-24 | Eli Lilly And Company | N- 2-substituted-3-(2-aminoethyl)-1H-indol-5-YL!-Amides: new 5-HT1F agonists |
| GB9523583D0 (en) * | 1995-11-17 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
| FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
| FR2763243A1 (fr) * | 1997-05-14 | 1998-11-20 | Pf Medicament | Utilisation d'amines indoliques comme medicaments antithrombotiques |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| US6602889B1 (en) | 1998-03-09 | 2003-08-05 | H. Lundbeck A.S. | 5-heteroaryl substituted indoles |
| WO2000000487A1 (en) * | 1998-06-30 | 2000-01-06 | Eli Lilly And Company | 5-ht1f agonists |
| EP1173432B9 (en) * | 1999-04-21 | 2008-10-15 | NPS Allelix Corp. | Piperidine-indole compounds having 5-ht6 affinity |
| WO2001034146A1 (en) * | 1999-11-08 | 2001-05-17 | Smithkline Beecham Corporation | Novel anti-infectives |
| NZ524675A (en) | 2000-10-20 | 2004-09-24 | Biovitrum Ab | 2-, 3-, 4-, or 5-substituted-N1-(benzensulfonyl) indoles and their use in therapy |
| DE10121217A1 (de) | 2001-04-30 | 2002-10-31 | Merck Patent Gmbh | 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden |
| AU2003239508A1 (en) | 2002-05-21 | 2003-12-12 | Bristol-Myers Squibb Company | Indole compounds useful as impdh inhibitors |
| MXPA05005701A (es) * | 2002-11-28 | 2005-08-16 | Suven Life Sciences Ltd | N-arilsulfonil indoles sustituidos en la posicion 3 que tienen afinidad por el receptor de la serotonina, proceso para su preparacion y composiciones farmaceuticas que los contienen. |
| US7332508B2 (en) * | 2002-12-18 | 2008-02-19 | Novo Nordisk A/S | Substituted homopiperidine, piperidine or pyrrolidine derivatives |
| WO2005005439A1 (en) * | 2003-07-09 | 2005-01-20 | Suven Life Sciences Limited | Benzothiazino indoles |
| US20050245540A1 (en) * | 2003-12-09 | 2005-11-03 | Fujisawa Pharmaceutical Co., Ltd. | New methods |
| WO2005121132A1 (ja) * | 2004-06-11 | 2005-12-22 | Shionogi & Co., Ltd. | 抗ｈｃｖ作用を有する縮合ヘテロ環化合物 |
| WO2007063418A2 (en) | 2005-04-13 | 2007-06-07 | Neuraxon, Inc. | Substituted indole compounds having nos inhibitory activity |
| SG172738A1 (en) * | 2005-07-29 | 2011-07-28 | 4Sc Ag | Novel heterocyclic nf-kb inhibitors |
| US7696229B2 (en) | 2006-02-17 | 2010-04-13 | Memory Pharmaceuticals Corporation | Compounds having 5-HT6 receptor affinity |
| JP5350219B2 (ja) | 2006-04-13 | 2013-11-27 | ニューラクソン，インコーポレーテッド | Ｎｏｓ阻害活性を有する１，５および３，６−置換インドール化合物 |
| WO2008021851A2 (en) * | 2006-08-09 | 2008-02-21 | Smithkline Beecham Corporation | Novel compounds as antagonists or inverse agonists for opioid receptors |
| TW200848021A (en) | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
| BRPI0820632A2 (pt) | 2007-11-16 | 2015-06-16 | Neuraxon Inc | Compostos de indol e métodos para tratamento de dor visceral |
| US9512111B2 (en) | 2010-11-08 | 2016-12-06 | Lycera Corporation | N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease |
| EP2846804B1 (en) | 2012-05-08 | 2017-11-29 | Merck Sharp & Dohme Corp. | TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE |
| AU2013259624B2 (en) | 2012-05-08 | 2017-10-19 | Lycera Corporation | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease |
| US9809561B2 (en) | 2013-12-20 | 2017-11-07 | Merck Sharp & Dohme Corp. | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
| WO2015095788A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | 2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE |
| WO2015095792A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Carbamate benzoxaxine propionic acids and acid derivatives for modulation of rorgamma activity and the treatment of disease |
| WO2015131035A1 (en) | 2014-02-27 | 2015-09-03 | Lycera Corporation | Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma & related therapeutic methods |
| EP3140291A4 (en) | 2014-05-05 | 2018-01-10 | Lycera Corporation | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease |
| EP3209641A4 (en) | 2014-05-05 | 2018-06-06 | Lycera Corporation | Benzenesulfonamido and related compounds for use as agonists of ror and the treatement of disease |
| EP3256450B1 (en) | 2015-02-11 | 2020-12-02 | Merck Sharp & Dohme Corp. | Substituted pyrazole compounds as ror-gamma-t inhibitors and uses thereof |
| JP2018515491A (ja) | 2015-05-05 | 2018-06-14 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγの作動薬及び疾患の療法として使用するジヒドロ−２Ｈ−ベンゾ［ｂ］［１，４］オキサジンスルホンアミド及び関連化合物 |
| KR20180025894A (ko) | 2015-06-11 | 2018-03-09 | 라이세라 코퍼레이션 | Rory의 작용제로서 사용하기 위한 아릴 디히드로-2h-벤조[b][1,4]옥사진 술폰아미드 및 관련 화합물 및 질환의 치료 |
| RU2018117503A (ru) | 2015-10-27 | 2019-11-28 | Мерк Шарп И Доум Корп. | ЗАМЕЩЕННЫЕ ИНДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RORγТ И ИХ ПРИМЕНЕНИЕ |
| AU2016344118A1 (en) | 2015-10-27 | 2018-05-10 | Merck Sharp & Dohme Corp. | Heteroaryl substituted benzoic acids as rorgammat inhibitors and uses thereof |
| JP2018531957A (ja) | 2015-10-27 | 2018-11-01 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | ＲＯＲγＴ阻害薬としての置換二環式ピラゾール化合物及びその使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
| US4833153A (en) * | 1985-11-08 | 1989-05-23 | Glaxo Group Limited | Indole derivatives |
| GB8600398D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| DE69132691T2 (de) * | 1990-06-07 | 2002-06-20 | Astrazeneca Ab, Soedertaelje | Indolderivate als 5-HT1-like Agonisten |
-
1992
- 1992-01-28 TW TW081100627A patent/TW263508B/zh active
- 1992-02-03 CA CA002101521A patent/CA2101521A1/en not_active Abandoned
- 1992-02-03 WO PCT/US1992/000556 patent/WO1992013856A1/en not_active Ceased
- 1992-02-03 EP EP92904837A patent/EP0571471B1/en not_active Expired - Lifetime
- 1992-02-03 FI FI933551A patent/FI933551A0/fi not_active Application Discontinuation
- 1992-02-03 DK DK92904837.9T patent/DK0571471T3/da active
- 1992-02-03 DE DE69208868T patent/DE69208868T2/de not_active Expired - Fee Related
- 1992-02-03 AU AU12637/92A patent/AU655456B2/en not_active Ceased
- 1992-02-03 AT AT92904837T patent/ATE135005T1/de not_active IP Right Cessation
- 1992-02-03 HU HU9302328A patent/HUT65766A/hu unknown
- 1992-02-03 CZ CS931656A patent/CZ165693A3/cs unknown
- 1992-02-03 KR KR1019930702398A patent/KR930703305A/ko not_active Ceased
- 1992-02-03 JP JP4505422A patent/JPH07121942B2/ja not_active Expired - Lifetime
- 1992-02-03 ES ES92904837T patent/ES2084347T3/es not_active Expired - Lifetime
- 1992-02-06 IL IL100888A patent/IL100888A0/xx unknown
- 1992-02-10 PT PT100114A patent/PT100114A/pt not_active Application Discontinuation
- 1992-02-10 MX MX9200569A patent/MX9200569A/es unknown
- 1992-02-11 IE IE044292A patent/IE920442A1/en not_active Application Discontinuation
- 1992-02-11 NZ NZ241584A patent/NZ241584A/en unknown
- 1992-02-11 MY MYPI92000204A patent/MY131298A/en unknown
- 1992-02-11 ZA ZA92969A patent/ZA92969B/xx unknown
- 1992-02-11 YU YU13792A patent/YU13792A/sh unknown
-
1993
- 1993-08-11 NO NO93932859A patent/NO932859L/no unknown
-
1996
- 1996-04-29 GR GR960401158T patent/GR3019778T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO932859D0 (no) | 1993-08-11 |
| JPH07121942B2 (ja) | 1995-12-25 |
| PT100114A (pt) | 1993-05-31 |
| CZ165693A3 (en) | 1994-05-18 |
| DE69208868D1 (de) | 1996-04-11 |
| TW263508B (OSRAM) | 1995-11-21 |
| KR930703305A (ko) | 1993-11-29 |
| MX9200569A (es) | 1992-08-01 |
| GR3019778T3 (en) | 1996-07-31 |
| ATE135005T1 (de) | 1996-03-15 |
| EP0571471B1 (en) | 1996-03-06 |
| IL100888A0 (en) | 1992-11-15 |
| HUT65766A (en) | 1994-07-28 |
| IE920442A1 (en) | 1992-08-12 |
| AU1263792A (en) | 1992-09-07 |
| EP0571471A1 (en) | 1993-12-01 |
| NZ241584A (en) | 1994-12-22 |
| ES2084347T3 (es) | 1996-05-01 |
| FI933551L (fi) | 1993-08-11 |
| DE69208868T2 (de) | 1996-10-17 |
| JPH06500122A (ja) | 1994-01-06 |
| NO932859L (no) | 1993-08-11 |
| YU13792A (sh) | 1994-11-15 |
| CA2101521A1 (en) | 1992-08-13 |
| HU9302328D0 (en) | 1993-10-28 |
| ZA92969B (en) | 1993-08-11 |
| FI933551A0 (fi) | 1993-08-11 |
| WO1992013856A1 (en) | 1992-08-20 |
| AU655456B2 (en) | 1994-12-22 |
| MY131298A (en) | 2007-08-30 |
| DK0571471T3 (da) | 1996-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI942395A7 (fi) | Indolijohdannaiset | |
| FI933551A7 (fi) | 5-heteroyyli-indolijohdannaisia | |
| DK43193D0 (da) | Indolderivater | |
| FI944969A7 (fi) | Indolijohdannaisia | |
| DE69208877D1 (de) | Chinuclidinderivate | |
| FI924160A7 (fi) | Benzanilidderivat | |
| FI935726A7 (fi) | Atsanorbornaanijohdannaisia | |
| FI924159L (fi) | Benzanilidderivat | |
| NO922182D0 (no) | Krystallinske oksatiolan-derivater | |
| FI920480A7 (fi) | Indolijohdannainen | |
| NO961475D0 (no) | Indol-derivater | |
| FI933697A7 (fi) | 3-Piperidinyylimetyylikarboksylaattisubstituoidut indolit | |
| DE69212058D1 (de) | Indol-Derivate | |
| FI925763L (fi) | Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat | |
| FI923726L (fi) | Sulfaterade glykosaminoglykanoidderivat | |
| DK0411150T3 (da) | Indolderivater | |
| FI930345L (fi) | Foerfarande foer framstaellning av renat akrylamidosulfonsyramonomerderivat | |
| FI935243L (fi) | Pyridonkarboxylsyraderivat | |
| TR26336A (tr) | SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI | |
| BR9206306A (pt) | Indóis | |
| FI925774A7 (fi) | Indolijohdannaiset | |
| FI920394A7 (fi) | 3-kinuklidiinijohdannaiset | |
| FI900641A7 (fi) | Indolijohdokset | |
| MX9206710A (es) | Derivados de piridinol | |
| FI924145L (fi) | 3-cykloalkylprop-2-enamidderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |